Curi Wealth Management, LLC 9 Meters Biopharma, Inc. Transaction History

Curi Wealth Management, LLC

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 08, 2022
SELL
$0.21 - $0.32 $421,601 - $642,440
-2,007,628 Reduced 96.86%
65,143 $14,000
Q2 2022

Aug 08, 2022
BUY
$0.26 - $0.64 $535,902 - $1.32 Million
2,061,164 Added 17757.94%
2,072,771 $541,000
Q1 2022

May 06, 2022
BUY
$0.52 - $1.0 $6,035 - $11,607
11,607 New
11,607 $11,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Curi Wealth Management, LLC Portfolio

Follow Curi Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Curi Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email